Expanding the liver donor pool through extended-criteria donation;Ausweitung des Spenderpools unter Verwendung Marginaler Organe

Chirurg

Volumn 79, Issue 2, 2008, Pages 130-134

  Pratschke, J ^a   Mittler, J ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Donor age; Extended criteria donors; Graft steatosis; Liver transplantation; Organ shortage

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DONOR; FATTY LIVER; FEMALE; GERMANY; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER; LIVER DISEASE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATION; RISK FACTOR; STATISTICS;

ADULT; AGE FACTORS; AGED; FATTY LIVER; FEMALE; GERMANY; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TISSUE DONORS;

EID: 39149101430     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-007-1458-6     Document Type: Article

References (24)

1. Agnes S, Avolio AW, Magalini SC et al. (1996) Marginal donors for patients on regular waiting list for liver transplantation. Transpl Int 9: 469
2. Barshes NR, Horwitz IB, Franzini L et al. (2007) Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant 7: 1265-1270
3. Borchert D, Glanemann M, Mogl M et al. (2005) Older liver graft transplantation, cholestasis, and synthetic graft function. Transpl Int 18: 709-715
4. Busuttil RW, Farmer DG, Yersiz H et al. (2005) Analysis of long term outcomes of 3200 liver transplantations over two decades: a single center experience. Ann Surg 11: 373-379
5. Busuttil RW 2, Tanaka K (2003) The utility of marginal donors in liver transplantation. Liver Transpl 9: 651-663
6. Chavin KD, Fiorini RN, Shafizadeh S et al. (2004) Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation. Am J Transplant 4: 1440-1447
7. Crowley H, Lewis WD, Gordon F et al. (2000) Steatosis in donor and transplant liver biopsies. Hum Pathol 31: 1209-1213
8. DeCarlis L, Collela G, Sansalone CV et al. (1999) Marginal donors in liver transplantation: the role of donor age. Transplant Proc 31: 397
9. Dodson SF, Bonham CA, Geller DA et al. (1999) Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 68: 1058-1061
10. Feng S, Goodrich NP, Bragg-Gresham JL et al. (2006) Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6: 783
11. Ghobrial RM, Steadman R, Gornbein J et al. (2001) A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 234: 384-393
12. Makowka L, Gordon RD, Todo S et al. (1987) Analysis of donor criteria for the prediction of outcome in clinical transplantation. Transplant Proc 19: 2378-2382
13. Maluf DG, Edwards EB, Kauffman HM (2006) Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation 82: 1653-1657
14. Marroquin CE, Marino G, Kuo PC et al. (2001) Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplantation of hepatitis C-negative livers. Liver Transpl 7: 762-768
15. Marsman WA, Wiesner RH, Rodriguez L et al. (1999) Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62: 1246-1251
16. MutimerDJ, Gunson B, Chen J et al. (2006) Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 81: 7-15
17. Oh CK, Sanfey HA, Pelletier SJ et al. (2000) Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant 14: 386-390
18. Saab S, Chang AJ, Comulada S et al. (2003) Outcomes of hepatitis C- and hepatitis B core antibody positive grafts in orthotopic liver transplantation. Liver Transpl 9: 1053-1061
19. Schemmer P, Nickkholgh A, Hinz U et al. (2007) Extended donor criteria have no negative impact on earl outcome after liver transplantation: a single-center multivariate analysis. Transplant Proc 39: 529-534
20. Silberhumer GR, Pokorny H, Hetz H et al. (2007) Combination of extended donor criteria and changes in the model for end-stage liver disease score predict patient survival primary dysfunction in liver transplantation: a retrospective analysis. Transplantation 83: 588-592
21. Strasberg SM, Howard TK, Molmenti EP et al. (1994) Selecting donor livers: risk factors for poor liver function after orthtopic liver transplantation. Hepatology 20: 829-838
22. Tector AJ, Mangus RS, Chestovich P et al. (2006) Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 244: 439-448
23. Totsuka E, Dodson F, Urakami A et al. (1999) Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg 5: 421-428
24. Verran D, Kusyk T, Painter D et al. (2003) Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 9: 500-505